Johnson & Johnson posts earnings that narrowly beat expectations and raises its full-year outlook.
Johnson & Johnsonssecond-quarter earnings were met with a shrug on Wall Street, but one of the drugmakers top executives insists the most powerful growth drivers are just starting to pick up spee… [+101 chars]